ArticleAdvances in therapy2024

A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor Inhibitor.

Roberto Caporali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.